Evidence map›Paper›PMID 35859981›Full record

ArticleCureus2022

Clinical Experience of Using an 8 French Newton Shaped Catheter (Neuro-EBU) During Endovascular Treatment: A Case Series of 21 Patients.

Kazushi Maeda, Yosuke Kawano, Yoshio Suyama, Satoru Kawarazaki, Kohei Irie, Kazuhisa Kuwabara, Shintaro Nagaoka, Hidefuku Gi, Yukihide Kanemoto

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Kazushi MaedaNeurological Surgery, Baba Memorial Hospital, Sakai, JPN.
Yosuke KawanoNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Yoshio SuyamaNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Satoru KawarazakiNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Kohei IrieNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Kazuhisa KuwabaraNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Shintaro NagaokaNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Hidefuku GiNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Yukihide KanemotoNeurosurgery, Baba Memorial Hospital, Sakai, JPN.
Neurological Surgery · USBaba Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first step in endovascular treatment is the stable placement of a guide catheter (GC) into the target parent vessel. However, sufficient GC stabilization is sometimes difficult to obtain when the approach route has severe tortuosity. Here, we report our experience with and the usefulness of the 8 French (Fr) Newton-shaped Neuro-EBU vascular catheter (SILUX Co., Ltd., Kawaguchi City, Saitama Prefecture, Japan), which is rigid over its entire length except near the tip, in a case series of 21 patients. Of the 21 cases, 19 cases were successfully treated using the Neuro-EBU. The 8 Fr Newton-shaped Neuro-EBU might be useful both as a special GC and as a wire exchange catheter when placement of the conventional GC is difficult due to severe tortuosity of the access route. Although rarely used, the Neuro-EBU catheter can serve as a practical alternative when the access route is challenging. To the best of our knowledge, there are no detailed reports on the technical use of the Newton-shaped vascular catheter in the field of neurointervention. We present the usefulness of the specially shaped 8 Fr guide catheter.

Indexed as

endovascularguide catheterneurointerventionnewton shaped catheterwire exchange

Identifiers

PMID35859981
PMCPMC9288855
OpenAlexW4283070969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.